High interleukin-8 serum levels independently predict long-term all-cause mortality in chronic heart failure
These findings suggest IL-8's unique role in HF pathophysiology and its potential as a biomarker and therapeutic target. Further research is needed to validate these results and explore the clinical utility of IL-8 modulation in HF management.
Authors
- Jan Traub (ORCID: https://orcid.org/0000-0001-8092-5967)
- Michael Klaus Schuhmann (ORCID: https://orcid.org/0000-0002-4014-7010)
- Niklas Beyersdorf (ORCID: https://orcid.org/0000-0002-9236-5415)
- Anna Frey (ORCID: https://orcid.org/0000-0002-2955-6753)
- Guido Stoll (ORCID: https://orcid.org/0000-0003-2474-5165)
- Stefan Frantz (ORCID: https://orcid.org/0000-0002-0301-6185)
- Ulrich Hofmann (ORCID: https://orcid.org/0000-0002-3681-2073)
- Stefan Störk (ORCID: https://orcid.org/0000-0002-1771-7249)
- Gustavo C. Ramos (ORCID: https://orcid.org/0000-0001-6668-364X)
Institutions
- University of Würzburg (DE)
- Universitätsklinikum Würzburg (DE)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-10-24
- DOI
- https://doi.org/10.3389/fcvm.2025.1677503
- Primary Topic
- Cardiac Fibrosis and Remodeling
- Type
- article
- Field-Weighted Citation Impact
- 0.00